Janux Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
JANX Nasdaq 2834 www.januxrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Janux Therapeutics, Inc.

JonesTrading Remains Bullish on Janux Therapeutics (JANX) With a $90 Price Target - Jun 24th, 2025 3:42 pm
Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer - May 15th, 2025 6:00 am
Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights - May 8th, 2025 2:01 pm
Janux commences Phase Ib studies in trial for prostate cancer treatment - May 6th, 2025 3:30 am
Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential - May 5th, 2025 8:10 am
Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates - May 5th, 2025 6:30 am
Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - May 5th, 2025 5:58 am
Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts? - Mar 28th, 2025 8:36 am
Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode? - Mar 26th, 2025 7:40 pm
Janux Therapeutics, Inc. (JANX): Among Stocks Receiving the Most Insider Love in March - Mar 25th, 2025 8:45 am
We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow - Mar 25th, 2025 7:39 am
Is Janux Therapeutics (JANX) a Worst High-Risk High-Reward Growth Stock to Buy? - Mar 20th, 2025 2:43 pm
Biotech Alert: Searches spiking for these stocks today - Mar 14th, 2025 10:15 am
Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently - Mar 5th, 2025 4:53 pm
Janux Therapeutics price target lowered to $41 from $62 at Scotiabank - Mar 1st, 2025 8:00 am
Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - Feb 27th, 2025 2:01 pm
Janux Therapeutics, Inc. (JANX): Among the Oversold Biotech Stocks to Buy Now - Feb 24th, 2025 11:07 am
Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer - Jan 24th, 2025 2:01 pm
Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million - Dec 6th, 2024 5:43 pm
Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Dec 4th, 2024 9:12 pm